Picotamide
Back to searchMolecule Structure
Scientific Name
Picotamide
Description of the Drug
Picotamide is a platelet aggregation inhibitor indicated in the treatment of myocardial infarction, thrombosis, cerebrovascular disorders, pulmonary emboli, and atherosclerosis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB13327
http://www.drugbank.ca/drugs/DB13327
Brand Name(s)
Not Available
Company Owner(s)
Not Available
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Thromboxane A2 receptor | SINGLE PROTEIN | INHIBITOR | CHEMBL2069 |
| Thromboxane-A synthase | SINGLE PROTEIN | INHIBITOR | CHEMBL1835 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL137025 |
| Human Metabolome Database | HMDB0256535 |
| DrugBank | DB13327 |
| PubChem: Thomson Pharma | 14902218 |
| PubChem | 4814 |
| LINCS | LSM-3497 |
| Nikkaji | J209.443F |
| BindingDB | 50103507 |
| EPA CompTox Dashboard | DTXSID40186498 |
| DrugCentral | 2161 |
| Brenda | 162376 |
| PubChem: Drugs of the Future | 12013156 |
| ChEBI | 93175 |
| ZINC | ZINC000000538174 |
